1:40 PM
 | 
Jul 10, 2018
 |  BC Extra  |  Politics & Policy

Trump administration may go beyond drug price blueprint

Recent drug price increases are prompting the Trump administration to consider taking steps that go beyond the drug pricing blueprint it released in May, John O’Brien, adviser to the HHS secretary and deputy assistant secretary for health policy, said Tuesday.

Speaking at an event sponsored by the Pew Charitable Trusts, O’Brien reiterated the goals of the blueprint, including injecting more competition into Medicare Part B drug purchasing. While he provided no details, he said that ultimately the administration’s actions “may extend beyond what was in the blueprint.”

Read the full 420 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >